Analyzing The Risks, Benefits, and Therapeutic Potential of Cannabis And Cannabinoids in Tumor Therapy - A Review

Poorti Sharma ^1*, Lukeshwari Sahu ¹

Study explores Cannabis use by metastatic tumor patients, analyzing active components, addressing gaps in research, and promoting informed medical guidance.

Abstract

Cancer patients dealing with metastatic tumors often turn to Cannabis and cannabinoids to alleviate symptoms and enhance their quality of life. Cannabis is used to address issues like pain, nausea, appetite loss, stress, sleep difficulties, and emotional distress for individuals facing cancer. While cannabinoids, such as CBD, may lead to side effects like fatigue, disorientation, psychological effects, and a dry throat, their usage has surpassed scientific research on both positive and negative effects. This study focuses on developing and validating a Nanotechnology-based methodology (NT-CBD) to measure active components in different Cannabis specimens, including both recreational and drug-type varieties. Fiber-type plant varieties are also examined for non-psychoactive chemicals with potential medicinal and dietary supplement applications. This review paper aims to understand the potential negative impacts of Cannabis and cannabinoids on normal human function, discussing both therapeutic uses for specific medical conditions and potential short-term and long-term adverse effects. Recognizing these effects is crucial, and training healthcare providers to guide cancer patients in the proper use of Cannabis can enhance safety and effectiveness, ensuring optimal symptom relief.

Keywords: Cannabis, Cannabinoids, Nanotechnology, Tumor therapy.

References

Afrin, F., Chi, M., Eamens, A. L., Duchatel, R. J., Douglas, A. M., Schneider, J., ... & Dun, M. D. (2020). Can hemp help? Low-THC cannabis and non-THC cannabinoids for the treatment of cancer. Cancers, 12(4), 1033.

Baroi, S., Saha, A., Bachar, R., & Bachar, S. C. (2020). Cannabinoid as Potential Aromatase Inhibitor Through Molecular Modeling and Screening for Anti-Cancer Activity: Cannabinoid as Potential Aromatase Inhibitor Through Molecular Modeling. Dhaka University Journal of Pharmaceutical Sciences, 19(1), 47-58.

Cherkasova, V., Wang, B., Gerasymchuk, M., Fiselier, A., Kovalchuk, O., & Kovalchuk, I. (2022). Use of cannabis and cannabinoids for treatment of cancer. Cancers, 14(20), 5142.

Fraguas-Sánchez, A. I., Torres-Suárez, A. I., Cohen, M., Delie, F., Bastida-Ruiz, D., Yart, L., ... & Fernández-Carballido, A. (2020). PLGA nanoparticles for the intraperitoneal administration of CBD in the treatment of ovarian cancer: In Vitro and In Ovo assessment. Pharmaceutics, 12(5), 439.

Gonçalves, E. C., Baldasso, G. M., Bicca, M. A., Paes, R. S., Capasso, R., & Dutra, R. C. (2020). Terpenoids, cannabimimetic ligands, beyond the cannabis plant. Molecules, 25(7), 1567.

Hardy, J., Haywood, A., Gogna, G., Martin, J., Yates, P., Greer, R., & Good, P. (2020). Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: a double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1: 1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Trials, 21, 1-8.

Hasan, N., Imran, M., Sheikh, A., Saad, S., Chaudhary, G., Jain, G. K., ... & Ahmad, F. J. (2022). Cannabis as a potential compound against various malignancies, legal aspects, advancement by exploiting nanotechnology and clinical trials. Journal of Drug Targeting, 30(7), 709-725.

Heblinski, M., Santiago, M., Fletcher, C., Stuart, J., Connor, M., McGregor, I. S., & Arnold, J. C. (2020). Terpenoids commonly found in Cannabis sativa do not modulate the actions of phytocannabinoids or endocannabinoids on TRPA1 and TRPV1 channels. Cannabis and cannabinoid research, 5(4), 305-317.

https://www.kaggle.com/datasets/corykjar/leafly-cannabis-strains-dataset

Johal, H., Devji, T., Chang, Y., Simone, J., Vannabouathong, C., & Bhandari, M. (2020). Cannabinoids in chronic non-cancer pain: a systematic review and meta-analysis. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders, 13, 1179544120906461.

Khodadadi, H., Salles, É. L., Jarrahi, A., Chibane, F., Costigliola, V., Yu, J. C., ... & Baban, B. (2020). Cannabidiol modulates cytokine storm in acute respiratory distress syndrome induced by simulated viral infection using synthetic RNA. Cannabis and cannabinoid research, 5(3), 197-201.

Krüger, M., van Eeden, T., & Beswa, D. (2022). Cannabis sativa cannabinoids as functional ingredients in snack foods—Historical and developmental aspects. Plants, 11(23), 3330.

Lipnik-Štangelj, M., & Razinger, B. (2020). A regulatory take on cannabis and cannabinoids for medicinal use in the European Union. Archives of Industrial Hygiene and Toxicology, 71(1), 12-18.

Mahmoudinoodezh, H., Telukutla, S. R., Bhangu, S. K., Bachari, A., Cavalieri, F., & Mantri, N. (2022). The transdermal delivery of therapeutic cannabinoids. Pharmaceutics, 14(2), 438.

Rabgay, K., Waranuch, N., Chaiyakunapruk, N., Sawangjit, R., Ingkaninan, K., & Dilokthornsakul, P. (2020). The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis. Journal of the American Pharmacists Association, 60(1), 225-234.

Reddy, T. S., Zomer, R., & Mantri, N. (2023). Nanoformulations as a strategy to overcome the delivery limitations of cannabinoids. Phytotherapy Research.

Riboulet-Zemouli, K. (2020). ‘Cannabis’ ontologies I: Conceptual issues with Cannabis and cannabinoids terminology. Drug Science, Policy and Law, 6, 2050324520945797.

Ritter, S., Zadik-Weiss, L., Almogi-Hazan, O., & Or, R. (2020). Cannabis, one health, and veterinary medicine: cannabinoids’ role in public health, food safety, and translational medicine. Rambam Maimonides Medical Journal, 11(1).

Sadhu, P. K., Rajput, A., Seth, A. K., Dash, D. K., Shah, N. V., Kumari, M., & Patel, S. (2020). A Combined Approach of Gold Nanoparticles with Cannabinoids for the Treatment of Cancer-A Review. International Journal of Pharmaceutical Research (09752366).

Sheriff, T., Lin, M. J., Dubin, D., & Khorasani, H. (2020). The potential role of cannabinoids in dermatology. Journal of Dermatological Treatment, 31(8), 839-845.

Turgeman, I., & Bar-Sela, G. (2019). Cannabis for cancer–illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology. Expert Opinion on Investigational Drugs, 28(3), 285-296.

Uziel, A., Gelfand, A., Amsalem, K., Berman, P., Lewitus, G. M., Meiri, D., & Lewitus, D. Y. (2020). Full-spectrum cannabis extract microdepots support controlled release of multiple phytocannabinoids for extended therapeutic effect. ACS applied materials & interfaces, 12(21), 23707-23716.

Xiong, X., Chen, S., Shen, J., You, H., Yang, H., Yan, C., ... & Zhou, P. (2022). Cannabis suppresses antitumor immunity by inhibiting JAK/STAT signaling in T cells through CNR2. Signal Transduction and Targeted Therapy, 7(1), 99.

Yekhtin, Z., Khuja, I., Meiri, D., Or, R., & Almogi-Hazan, O. (2022). Differential effects of D9 tetrahydrocannabinol (THC)-and cannabidiol (CBD)-Based cannabinoid treatments on macrophage immune function in vitro and on gastrointestinal inflammation in a murine model. Biomedicines, 10(8), 1793.

Zenone, M., Snyder, J., & Caulfield, T. (2020). Crowdfunding cannabidiol (CBD) for cancer: hype and misinformation on GoFundMe. American Journal of Public Health, 110(S3), S294-S299.